KINDRED BIOSCIENCES
Kindred Biosciences is a veterinary biotechnology company, focuses on developing therapies for dogs, cats, and horses. It develops canine, feline, and equine antibodies for the treatment of diseases in companion animals. Its strategy is to identify compounds and targets that have already demonstrated safety and efficacy in humans and to develop therapeutics based on these validated compounds and targets for animal companions. Their mission is to bring innovative biologics to veterinary medicine because they believe their pets deserve the same kinds of safe and effective medicines that human family members enjoy. The company was incorporated in 2012 and is based in San Francisco, California.
KINDRED BIOSCIENCES
Industry:
Animal Feed Biotechnology Health Care Pet Veterinary
Founded:
2012-01-01
Address:
Burlingame, California, United States
Country:
United States
Website Url:
http://www.kindredbio.com
Total Employee:
101+
Status:
Active
Contact:
888-608-2542
Email Addresses:
[email protected]
Total Funding:
62.13 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Font Awesome
Similar Organizations
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics.
Rakuten Medical
Rakuten Medical is a Bio-technology Company.
Aura Biosciences
Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.
BorrowMyDoggy
BorrowMyDoggy is a trusted community where local dog lovers help take care of dogs for walkies.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Destination Dog Ranch
Destination Dog Ranch is the dog destination that provides dog training and lodging services.
DIG Labs
Unleashing the power of visual data to supercharge brand experiences and closely connect companies to their consumers.
Digitail
Digitail is redesigning how pet care is delivered in today's world.
Embark
Embark offers dog DNA testing that ends preventable diseases in dogs.
Hannah The Pet Society
Hannah The Pet Society offers veterinary care and behavior training.
JustFoodForDogs
JustFoodForDogs manufactures scientifically proven, whole food diets made fresh daily for dogs.
Koona E&T
Kuna ENT is one of the leading companies in the animal companion industry in Korea.
MedVet
MedVet is a veterinary company that offers cardiology, critical care, and emergency medical services.
My Pet's Vet Group
My Pet's Vet Group is to deliver quality lifelong veterinary care to cats and dogs, and helping puppies and rescues find homes.
Smalls
Smalls is a direct-to-consumer pet food company that produces human-grade and fresh food for cats.
SnoutID
SnoutID is a veterinary technology solution that helps the practice support team to concentrate on customer service and patient care.
Vetchat
Vetchat provides pre-clinic veterinary consultations online via video consultations and on demand chat.
Veterinary Emergency Group
Veterinary Emergency Group provides animals and their families with timely medical care for acute problems at times when pets need it.
Vets First Choice
Vets First Choice provides veterinary practices with an online pharmacy and home delivery services.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
SLR Capital Partners
SLR Capital Partners investment in Post-IPO Debt - Kindred Biosciences
General American Investors Company,Inc
General American Investors Company,Inc investment in Post-IPO Equity - Kindred Biosciences
Official Site Inspections
http://www.kindredbio.com Semrush global rank: 8.11 M Semrush visits lastest month: 366
- Host name: aeedc42b70c898c66.awsglobalaccelerator.com
- IP address: 3.33.139.32
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
More informations about "Kindred Biosciences" on Search Engine
Elanco Announces Agreement to Acquire Kindred …
Jun 16, 2021 Elanco will acquire all outstanding stock of Kindred Biosciences at a price of $9.25 per share, or approximately $440 million, a premium of 52% based on the 30-day average. Transaction brings three …See details»
Kindred Biosciences - Crunchbase Company Profile & Funding
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses. Acquired by. Elanco. Burlingame, California, United States. 51-100. Post-IPO Debt. Public. www.kindredbio.com. 19,070. Highlights. Stock Symbol NASDAQ:KIN. Total Funding Amount. Unlock for free. Contacts 28. Employee …See details»
Elanco Closes Acquisition of Kindred Biosciences
Aug 30, 2021 Transaction Details. Elanco acquired all outstanding stock of Kindred Biosciences at a price of $9.25 per share, or approximately $444 million. Elanco utilized its revolving credit facility and...See details»
June 16, 2021 Elanco Animal Health to Acquire
16, 2021. Animal Health to Acquire. Important Information for Investors and Stockholders. This presentation does not constitute a solicitation of any vote or approval in connection with the proposed acquisition of Kindred Biosciences, Inc. (“KindredBio”) by Elanco Animal Health Incorporated (“Elanco” and such proposed acquisition, the “Merger”).See details»
Elanco acquires Kindred Biosciences - 2021-03-31 - Crunchbase
Mar 31, 2021 Overview. Acquired Organization: Kindred Biosciences Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses. Acquiring Organization: Elanco Elanco develops, manufactures and markets products for companion and food animals. Announced Date Mar 31, 2021. …See details»
Kindred Biosciences Announces Agreement Granting Elanco
SAN FRANCISCO, Dec. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company focused on saving and improving the lives of pets, today announced an agreement...See details»
Kindred Biosciences Announces Plan to Strengthen its Strategic …
Jun 8, 2020 Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and...See details»
Kindred Biosciences Announces Agreement Granting Elanco …
SAN FRANCISCO, Dec. 11, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a biopharmaceutical company focused on saving and improving the lives of pets, today announced an...See details»
Kindred Biosciences Submits Efficacy Data For KIND-030 As …
Feb 25, 2021 Kindred Biosciences Inc (NASDAQ: KIN) has submitted efficacy data to support the prophylactic indication for KIND-030 to the United States Department of Agriculture Center for Veterinary...See details»
Elanco Announces Agreement to Acquire Kindred Biosciences
Jun 16, 2021 Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.See details»
Kindred Biosciences Awarded a Contract by the National Cancer …
SAN FRANCISCO, Sept. 10, 2019 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN ), a commercial-stage biopharmaceutical company developing novel drugs and biologics, today announced that...See details»
Kindred Biosciences, Inc. (KIN) CEO Dr. Richard Chin on Q1 …
May 12, 2021 Kindred Biosciences, Inc. (KIN) Q1 2021 Results Conference Call May 11, 2021 4:30 PM ET. Company Participants. Dr. Richard Chin - CEO. Wendy Wee - CFO. Katja Buhrer - VP of Corporate...See details»
Kindred Biosciences Announces Expansion of Manufacturing
SAN FRANCISCO, Oct. 7, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: KIN), a biopharmaceutical company developing novel biologics, today announced it has expanded an agreement with...See details»
Kindred Biosciences - Funding, Financials, Valuation & Investors
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.See details»
Elanco Announces Agreement to Acquire Kindred Biosciences
Jun 16, 2021 Elanco will acquire all outstanding stock of Kindred Biosciences at a price of $9.25 per share, or approximately $440 million, a premium of 52% based on the 30-day average. Transaction brings...See details»
Kindred Biosciences Announces COVID-19 Vaccine …
May 20, 2020 Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family members enjoy.See details»
Kindred Biosciences Announces Expansion of Manufacturing …
Oct 7, 2020 Kindred Biosciences is a biopharmaceutical company developing innovative biologics. The company has a deep pipeline of novel biologics in development across many therapeutic classes, alongside...See details»
Kindred Biosciences Announces Positive Results from Pilot Field ...
Dec 21, 2020 Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and...See details»
Kindred Biosciences - Contacts, Employees, Board Members, …
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.See details»
Kindred Biosciences, Inc. | Devex
Learn more about Kindred Biosciences, Inc.'s jobs, projects, latest news, contact information and geographical presence.See details»